Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Glucose Health, Inc. (GLUC : OTC)
 
 • Company Description   
Glucose Health, Inc. is involved in manufacturing dietary supplements for Type 2 diabetes. The company's principal product is Glucose Health natural blood sugar maintenance product. Glucose Health, Inc. is based in Bentonville, Arkansas.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.01 Daily Weekly Monthly
20 Day Moving Average: 21,780 shares
Shares Outstanding: 13.85 (millions)
Market Capitalization: $27.84 (millions)
Beta: 3.35
52 Week High: $8.98
52 Week Low: $1.77
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -13.36% -10.66%
12 Week -27.44% -28.16%
Year To Date -65.93% -71.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
609 SW 8TH STREET 6TH FLOOR
-
BENTONVILLE,AR 72712
USA
ph: 479-802-3827
fax: -
info@glucosehealthinc.com http://www.glucosehealthinc.com
 
 • General Corporate Information   
Officers
Murray Fleming - Chief Executive Officer
Hal Kravitz - Director
Gerry David - Director
Peggy Knight - Executive Vice President
William Gallagher - Director

Peer Information
Glucose Health, Inc. (BJCT)
Glucose Health, Inc. (CADMQ)
Glucose Health, Inc. (APNO)
Glucose Health, Inc. (UPDC)
Glucose Health, Inc. (IMTIQ)
Glucose Health, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 379894108
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 02/02/22
Share - Related Items
Shares Outstanding: 13.85
Most Recent Split Date: (:1)
Beta: 3.35
Market Capitalization: $27.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/02/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -18.12%
ROE
09/30/21 - -
06/30/21 - -
03/31/21 - -
ROA
09/30/21 - -
06/30/21 - -
03/31/21 - -
Current Ratio
09/30/21 - -
06/30/21 - -
03/31/21 - -
Quick Ratio
09/30/21 - -
06/30/21 - -
03/31/21 - -
Operating Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Net Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Pre-Tax Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Book Value
09/30/21 - -
06/30/21 - -
03/31/21 - -
Inventory Turnover
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Equity
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Capital
09/30/21 - -
06/30/21 - -
03/31/21 - -
 

Powered by Zacks Investment Research ©